116 related articles for article (PubMed ID: 12816733)
21. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
Kandil DH; Cooper K
Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
23. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
[TBL] [Abstract][Full Text] [Related]
24. Gene expression in lung adenocarcinomas of smokers and nonsmokers.
Powell CA; Spira A; Derti A; DeLisi C; Liu G; Borczuk A; Busch S; Sahasrabudhe S; Chen Y; Sugarbaker D; Bueno R; Richards WG; Brody JS
Am J Respir Cell Mol Biol; 2003 Aug; 29(2):157-62. PubMed ID: 12600827
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.
Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M
Oncogene; 2004 Feb; 23(5):1166-76. PubMed ID: 14647414
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
27. Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells.
Chen JT; Lin TS; Chow KC; Huang HH; Chiou SH; Chiang SF; Chen HC; Chuang TL; Lin TY; Chen CY
Am J Respir Cell Mol Biol; 2006 Mar; 34(3):264-73. PubMed ID: 16254251
[TBL] [Abstract][Full Text] [Related]
28. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
29. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
[TBL] [Abstract][Full Text] [Related]
30. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M
Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568
[TBL] [Abstract][Full Text] [Related]
31. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
32. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
[TBL] [Abstract][Full Text] [Related]
33. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.
Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y
Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer.
Chen Y; Pacyna-Gengelbach M; Ye F; Knösel T; Lund P; Deutschmann N; Schlüns K; Kotb WF; Sers C; Yasumoto H; Usui T; Petersen I
J Pathol; 2007 Mar; 211(4):431-8. PubMed ID: 17236181
[TBL] [Abstract][Full Text] [Related]
35. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
Murthy SS; Shen T; De Rienzo A; Lee WC; Ferriola PC; Jhanwar SC; Mossman BT; Filmus J; Testa JR
Oncogene; 2000 Jan; 19(3):410-6. PubMed ID: 10656689
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
37. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma.
Aviel-Ronen S; Lau SK; Pintilie M; Lau D; Liu N; Tsao MS; Jothy S
Mod Pathol; 2008 Jul; 21(7):817-25. PubMed ID: 18469798
[TBL] [Abstract][Full Text] [Related]
38. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I
J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
[TBL] [Abstract][Full Text] [Related]
39. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
[TBL] [Abstract][Full Text] [Related]
40. HPP1-mediated tumor suppression requires activation of STAT1 pathways.
Elahi A; Zhang L; Yeatman TJ; Gery S; Sebti S; Shibata D
Int J Cancer; 2008 Apr; 122(7):1567-72. PubMed ID: 18059030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
